ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women

PRINCETON, NJ / ACCESSWIRE / July 18, 2023 / This month, Agile Therapeutics, Inc. (NASDAQ: AGRX) announced partnerships with FPA Women's Health and vitaCare Prescription Services that will expand access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system, its low-dose weekly birth control patch. The news builds on earlier partnerships that have been steadily making the patch more available, including an agreement signed in August of last year making Twirla available on the Nurx telehealth platform. Both Nurx and FPA Women's Health have decided to make Twirla the exclusive contraceptive patch they offer.

Agile Therapeutics, Inc., Tuesday, July 18, 2023, Press release picture

As expanded access across telehealth platforms and regional clinics helps push Agile closer to its $25-$30 million target net revenue for the year, it also expands access to a safe and effective birth control option.

Telehealth Platforms Help Fill Reproductive Healthcare Gaps In America's Contraception Landscape

Nurx and other telehealth companies that Agile is adding to its growing roster of partners provide birth control prescriptions, emergency contraception and other basic healthcare services to patients nationwide. Being able to get prescriptions written by licensed healthcare professionals and then delivered is a convenient, time-saving option for many.

But it can also be critical for patients who otherwise may not have access to affordable, reliable reproductive healthcare. More than 19 million women of reproductive age in the United States live in a contraceptive desert - a county with less than one health clinic offering publicly funded contraception per 1,000 women. Approximately 1.2 million of those women live in counties without any health center at all.

For these patients, accessing birth control or emergency contraception can require hours of travel, taking time off work or paying for childcare while they go to their appointment - making the total cost of getting birth control a burden they might not be able to afford.

Access to birth control provides far broader benefits to women and society as a whole. Teen pregnancies declined 75% between 1991 and 2019 in the United States, for example, and that's driven in large part by increased effective use of contraceptives. Contraception has also prevented an estimated 272,000 maternal deaths worldwide.

Outside of physical health, having access to birth control increases a woman's chances of enrolling in college and their chances of graduating. Those who do choose to start a family when they're ready are less likely to live in poverty, which, in turn, improves health, well-being and access to opportunities for their children.

So platforms like Nurx give women the flexibility to schedule virtual doctor appointments that they can attend from the comfort of their own homes without having to take time off work or pay for childcare. Meanwhile, free shipping ensures that their birth control is affordable.

Featured photo by Jornada Produtora on Unsplash.

Contact:

Matt Riley - Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

SOURCE: Agile Therapeutics, Inc.



View source version on accesswire.com:
https://www.accesswire.com/768616/Agile-Therapeutics-Partners-With-Telehealth-Platforms-To-Expand-Access-To-Weekly-Birth-Control-Patch-To-Millions-Of-Women

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.